$0.67 EPS Expected for DENTSPLY SIRONA Inc. (NASDAQ:XRAY) This Quarter

Wall Street brokerages predict that DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) will post $0.67 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have provided estimates for DENTSPLY SIRONA’s earnings, with the lowest EPS estimate coming in at $0.61 and the highest estimate coming in at $0.72. DENTSPLY SIRONA reported earnings of $0.72 per share in the same quarter last year, which would indicate a negative year over year growth rate of 6.9%. The company is expected to announce its next earnings results before the market opens on Monday, January 1st.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full year earnings of $3.10 per share for the current financial year, with EPS estimates ranging from $3.01 to $3.17. For the next year, analysts expect that the company will report earnings of $3.38 per share, with EPS estimates ranging from $3.15 to $3.49. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that that provide coverage for DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last posted its quarterly earnings results on Monday, February 28th. The medical instruments supplier reported $0.76 EPS for the quarter, missing the Zacks’ consensus estimate of $0.79 by ($0.03). The company had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.13 billion. DENTSPLY SIRONA had a return on equity of 12.51% and a net margin of 9.90%. The company’s revenue for the quarter was up .6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.87 earnings per share.

XRAY has been the topic of a number of research analyst reports. The Goldman Sachs Group cut their price target on shares of DENTSPLY SIRONA from $66.00 to $59.00 and set a “neutral” rating on the stock in a report on Tuesday, March 1st. Barrington Research lowered their price objective on shares of DENTSPLY SIRONA from $79.00 to $72.00 in a research note on Tuesday, March 1st. Morgan Stanley began coverage on shares of DENTSPLY SIRONA in a research note on Monday, January 31st. They issued an “overweight” rating and a $62.00 price objective for the company. Credit Suisse Group lowered their price objective on shares of DENTSPLY SIRONA from $68.00 to $67.00 and set an “outperform” rating for the company in a research note on Tuesday, March 1st. Finally, TheStreet lowered shares of DENTSPLY SIRONA from a “b-” rating to a “c+” rating in a research note on Friday, March 18th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Buy” and an average target price of $66.00.

Hedge funds have recently added to or reduced their stakes in the business. Optimal Asset Management Inc. raised its position in shares of DENTSPLY SIRONA by 0.3% in the 3rd quarter. Optimal Asset Management Inc. now owns 68,883 shares of the medical instruments supplier’s stock valued at $3,999,000 after purchasing an additional 186 shares during the last quarter. Park Avenue Securities LLC raised its position in shares of DENTSPLY SIRONA by 4.6% in the 3rd quarter. Park Avenue Securities LLC now owns 4,380 shares of the medical instruments supplier’s stock valued at $254,000 after purchasing an additional 194 shares during the last quarter. State of Michigan Retirement System raised its position in shares of DENTSPLY SIRONA by 0.4% in the 4th quarter. State of Michigan Retirement System now owns 55,049 shares of the medical instruments supplier’s stock valued at $3,071,000 after purchasing an additional 200 shares during the last quarter. Mutual of America Capital Management LLC raised its position in shares of DENTSPLY SIRONA by 0.7% in the 4th quarter. Mutual of America Capital Management LLC now owns 28,920 shares of the medical instruments supplier’s stock valued at $1,613,000 after purchasing an additional 201 shares during the last quarter. Finally, Signaturefd LLC raised its position in shares of DENTSPLY SIRONA by 13.0% in the 4th quarter. Signaturefd LLC now owns 1,786 shares of the medical instruments supplier’s stock valued at $100,000 after purchasing an additional 205 shares during the last quarter. 97.32% of the stock is owned by institutional investors and hedge funds.

Shares of NASDAQ XRAY traded up $0.32 during mid-day trading on Friday, reaching $49.07. The company had a trading volume of 887,750 shares, compared to its average volume of 1,872,640. The business’s 50-day moving average is $51.28 and its 200-day moving average is $53.53. The company has a current ratio of 1.55, a quick ratio of 1.12 and a debt-to-equity ratio of 0.38. The stock has a market cap of $10.57 billion, a price-to-earnings ratio of 25.56, a price-to-earnings-growth ratio of 1.57 and a beta of 0.86. DENTSPLY SIRONA has a 52 week low of $47.06 and a 52 week high of $69.54.

The company also recently declared a quarterly dividend, which was paid on Friday, April 8th. Shareholders of record on Friday, March 25th were given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 1.02%. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Thursday, March 24th. DENTSPLY SIRONA’s dividend payout ratio is presently 26.04%.

About DENTSPLY SIRONA (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Featured Stories

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.